Cargando…
Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression
Cell senescence is a permanent growth arrest following extended proliferation. Cultured cancer cells including metastatic melanoma cells often appear immortal (proliferate indefinitely), while uncultured benign nevi (moles) show senescence markers. Here, with new explantation methods, we investigate...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123747/ https://www.ncbi.nlm.nih.gov/pubmed/21418545 http://dx.doi.org/10.1111/j.1755-148X.2011.00850.x |
_version_ | 1782207020905005056 |
---|---|
author | Soo, Julia K MacKenzie Ross, Alastair D Kallenberg, David M Milagre, Carla Heung Chong, W Chow, Jade Hill, Lucy Hoare, Stacey Collinson, Rebecca S Hossain, Mehnaz Keith, W Nicol Marais, Richard Bennett, Dorothy C |
author_facet | Soo, Julia K MacKenzie Ross, Alastair D Kallenberg, David M Milagre, Carla Heung Chong, W Chow, Jade Hill, Lucy Hoare, Stacey Collinson, Rebecca S Hossain, Mehnaz Keith, W Nicol Marais, Richard Bennett, Dorothy C |
author_sort | Soo, Julia K |
collection | PubMed |
description | Cell senescence is a permanent growth arrest following extended proliferation. Cultured cancer cells including metastatic melanoma cells often appear immortal (proliferate indefinitely), while uncultured benign nevi (moles) show senescence markers. Here, with new explantation methods, we investigated which classes of primary pigmented lesions are typically immortal. Nevi yielded a few proliferating cells, consistent with most nevus cells being senescent. No nevus culture (0/28) appeared immortal. Some thin and thick melanoma cultures proved immortal under these conditions, but surprisingly few (4/37). All arrested cultures displayed three senescence markers in some cells: β-galactosidase, nuclear p16, and heterochromatic foci/aggregates. However, melanoma cultures also showed features of telomeric crisis (arrest because of ultrashort telomeres). Moreover, crisis markers including anaphase bridges were frequent in uncultured vertical growth-phase (VGP) melanomas. Conversely, all immortal melanoma cultures expressed telomerase reverse transcriptase and telomerase, showing aneuploidy. The findings suggest that primary melanomas are typically precrisis, with immortalization/telomere maintenance as a late event. |
format | Online Article Text |
id | pubmed-3123747 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-31237472011-06-28 Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression Soo, Julia K MacKenzie Ross, Alastair D Kallenberg, David M Milagre, Carla Heung Chong, W Chow, Jade Hill, Lucy Hoare, Stacey Collinson, Rebecca S Hossain, Mehnaz Keith, W Nicol Marais, Richard Bennett, Dorothy C Pigment Cell Melanoma Res Signaling & Cell Biology Cell senescence is a permanent growth arrest following extended proliferation. Cultured cancer cells including metastatic melanoma cells often appear immortal (proliferate indefinitely), while uncultured benign nevi (moles) show senescence markers. Here, with new explantation methods, we investigated which classes of primary pigmented lesions are typically immortal. Nevi yielded a few proliferating cells, consistent with most nevus cells being senescent. No nevus culture (0/28) appeared immortal. Some thin and thick melanoma cultures proved immortal under these conditions, but surprisingly few (4/37). All arrested cultures displayed three senescence markers in some cells: β-galactosidase, nuclear p16, and heterochromatic foci/aggregates. However, melanoma cultures also showed features of telomeric crisis (arrest because of ultrashort telomeres). Moreover, crisis markers including anaphase bridges were frequent in uncultured vertical growth-phase (VGP) melanomas. Conversely, all immortal melanoma cultures expressed telomerase reverse transcriptase and telomerase, showing aneuploidy. The findings suggest that primary melanomas are typically precrisis, with immortalization/telomere maintenance as a late event. Blackwell Publishing Ltd 2011-06 2011-03-21 /pmc/articles/PMC3123747/ /pubmed/21418545 http://dx.doi.org/10.1111/j.1755-148X.2011.00850.x Text en Copyright © 2011 John Wiley & Sons A/S http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Signaling & Cell Biology Soo, Julia K MacKenzie Ross, Alastair D Kallenberg, David M Milagre, Carla Heung Chong, W Chow, Jade Hill, Lucy Hoare, Stacey Collinson, Rebecca S Hossain, Mehnaz Keith, W Nicol Marais, Richard Bennett, Dorothy C Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression |
title | Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression |
title_full | Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression |
title_fullStr | Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression |
title_full_unstemmed | Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression |
title_short | Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression |
title_sort | malignancy without immortality? cellular immortalization as a possible late event in melanoma progression |
topic | Signaling & Cell Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123747/ https://www.ncbi.nlm.nih.gov/pubmed/21418545 http://dx.doi.org/10.1111/j.1755-148X.2011.00850.x |
work_keys_str_mv | AT soojuliak malignancywithoutimmortalitycellularimmortalizationasapossiblelateeventinmelanomaprogression AT mackenzierossalastaird malignancywithoutimmortalitycellularimmortalizationasapossiblelateeventinmelanomaprogression AT kallenbergdavidm malignancywithoutimmortalitycellularimmortalizationasapossiblelateeventinmelanomaprogression AT milagrecarla malignancywithoutimmortalitycellularimmortalizationasapossiblelateeventinmelanomaprogression AT heungchongw malignancywithoutimmortalitycellularimmortalizationasapossiblelateeventinmelanomaprogression AT chowjade malignancywithoutimmortalitycellularimmortalizationasapossiblelateeventinmelanomaprogression AT hilllucy malignancywithoutimmortalitycellularimmortalizationasapossiblelateeventinmelanomaprogression AT hoarestacey malignancywithoutimmortalitycellularimmortalizationasapossiblelateeventinmelanomaprogression AT collinsonrebeccas malignancywithoutimmortalitycellularimmortalizationasapossiblelateeventinmelanomaprogression AT hossainmehnaz malignancywithoutimmortalitycellularimmortalizationasapossiblelateeventinmelanomaprogression AT keithwnicol malignancywithoutimmortalitycellularimmortalizationasapossiblelateeventinmelanomaprogression AT maraisrichard malignancywithoutimmortalitycellularimmortalizationasapossiblelateeventinmelanomaprogression AT bennettdorothyc malignancywithoutimmortalitycellularimmortalizationasapossiblelateeventinmelanomaprogression |